All Stories

  1. Shigella Infections in the United States Veterans Health Administration
  2. RSV Genomic Characterization
  3. P-2327. West Nile Virus Disease in the Veterans Health Administration (VHA), 2010-2023
  4. P-2328. Influenza and RSV Surveillance in the US Veterans Health Administration (VHA): 2023-2024 Season
  5. RSV Vaccine Effectiveness
  6. Risk Factors for Extrapulmonary Tuberculosis Among US Veterans, 1990–2022
  7. Clinically Defined Lymphogranuloma Venereum among US Veterans with Human Immunodeficiency Virus, 2016–2023
  8. Mpox in the Veterans Health Administration
  9. 898. Influenza Surveillance in the US Veterans Health Administration (VHA): 2022-2023 Season
  10. 1992. Two Decades of Lyme Disease in the U.S. Veterans Health Administration Detected Via Automated Surveillance Methodology, October 1999 - September 2022
  11. 899. Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration (VHA)
  12. 1797. Pneumococcal Vaccination in Veterans 65 years and older with Pneumococcus in the Veterans Health Administration (VHA) since November 2021
  13. Norovirus hospitalizations and mortality in Veterans Health Administration
  14. Coccidioidomycosis (Valley Fever) in the Veterans Health Administration
  15. Trends in Follow-up Testing Among Patients Positive for Chlamydia and Gonorrhea in the Veterans Health Administration, 2013 to 2019
  16. 2220. Trends in Follow-up Testing among Patients Positive for Chlamydia and Gonorrhea in the Veterans Health Administration (VHA), 2013-2019
  17. 1967. Receipt of Influenza Vaccination as Predictor of COVID-19 Vaccination among United States Veterans
  18. Exposure Sources Among Veterans With Elevated Blood Lead Levels, United States, 2015‒2021
  19. Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016–2019
  20. Association of Secretor Status and Recent Norovirus Infection With Gut Microbiome Diversity Metrics in a Veterans Affairs Population
  21. Public health surveillance in the U.S. Department of Veterans Affairs: evaluation of the Praedico surveillance system
  22. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
  23. 1201. Diphtheria in Veterans Health Administration (VHA), 2000-2021
  24. 227. Epidemiology of bloodstream infections in Veterans Health Administration, 2010-2020
  25. 1444. Influenza Surveillance in the Veterans Health Administration (VHA): 2020-2021 Season
  26. 702. Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016–19
  27. Adapting the Surveillance Platform for Enteric and Respiratory Infectious Organisms at United States Veterans Affairs Medical Centers (SUPERNOVA) for COVID-19 Among Hospitalized Adults: Surveillance Protocol
  28. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021
  29. Respiratory co-infections with COVID-19 in the Veterans Health Administration, 2020
  30. COVID-19–Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study
  31. COVID-19 Infections Among Healthcare Personnel in the United States Veterans Health Administration, March to August, 2020
  32. Risk for In-Hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020
  33. 1534. Gonorrhea Testing and Ceftriaxone Resistance in the Department of Veterans Affairs (VA), 2010-2019
  34. 1709. Influenza Surveillance in the U.S. Department of Veterans Affairs (VA): 2019-2020 Season
  35. Candida auris in the US Department of Veterans’ Affairs (VA)
  36. Prevalence of Drug-Resistant Mycobacterium tuberculosis in the Veterans Health Administration (VHA)
  37. Lessons Learned From a Decade of Dental Lookback Investigations in the Department of Veterans’ Affairs (VA): 2009–2019
  38. Lack of Evidence of Transmission of Bloodborne Viruses by Improperly Reprocessed Fiberoptic Endoscopes
  39. 1718. Respiratory Syncytial Virus (RSV) Surveillance in the Department of Veterans Affairs (VA), 2010-2018
  40. 397. Respiratory Coinfections with COVID-19 in Veterans Health Administration (VA), 2020
  41. Incidence, Etiology, and Severity of Acute Gastroenteritis Among Prospectively Enrolled Patients in 4 Veterans Affairs Hospitals and Outpatient Centers, 2016–2018
  42. Validation of Acute Gastroenteritis-related International Classification of Diseases, Clinical Modification Codes in Pediatric and Adult US Populations
  43. 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
  44. 1882. Tuberculosis in the Department of Veterans Affairs: Missed Opportunities for Prevention
  45. 2313. Influenza and Respiratory Syncytial Virus (RSV) Surveillance in the US Department of Veterans Affairs (VA): 2018–2019 Season
  46. Acute Hepatitis A Infection and Vaccination in the Veterans Health Administration
  47. Acute Hepatitis A Infections among Veterans in Outbreak States, 2016-2018
  48. Trends in Incidence of Norovirus-associated Acute Gastroenteritis in 4 Veterans Affairs Medical Center Populations in the United States, 2011–2015
  49. Carbon monoxide poisoning surveillance in the Veterans Health Administration, 2010–2017
  50. 1499. Gonorrhea and Chlamydia Infections in the Department of Veterans Affairs (VA), 2013–2017
  51. 2504. Influenza Surveillance and Outbreaks in the US Department of Veterans Affairs (VA): 2017–2018 Season
  52. Zika virus infection in the Veterans Health Administration (VHA), 2015-2016
  53. Influenza infections among U.S. Veterans.
  54. Epidemiologic Review of Veterans Health Administration Patients with Isolation of Nontuberculous Mycobacteria after Cardiopulmonary Bypass Procedures
  55. Enhanced Influenza Surveillance Using Telephone Triage and Electronic Syndromic Surveillance in the Department of Veterans Affairs, 2011-2015
  56. Firearm Injury Encounters in the Veterans Health Administration (VHA), 2010-2015
  57. Carbon Monoxide Poisoning in the Veterans Health Administration, 2010 - 2016
  58. Comparative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines among Veterans: 2015–2016 and 2016–2017 Seasons
  59. Factors for Hospitalizations and Neurologic Complications in Zika Virus Infection in the Department of Veterans Affairs (VA)
  60. Incidence of Norovirus-Associated Acute Gastroenteritis in Four Veteran’s Affairs Medical Center Populations in the United States, 2011–2015
  61. Are current screening protocols for chronic hepatitis B virus infection adequate?
  62. Chikungunya Fever Cases Identified in the Veterans Health Administration System, 2014
  63. Improving the Value Proposition of Surveillance Tools: Innovative Uses for VA ESSENCE
  64. Enhancing Biosurveillance Specificity Using PraedicoTM, A Next Generation Application
  65. Epidemiologic Review of Carbapenem-Resistant Enterobacteriaceae, Duodenoscopes, and Endoscopic Ultrasonography in the Department of Veterans Affairs
  66. Influenza Surveillance in the Department of Veterans Affairs (VA): 2015–2016 Season
  67. Zika Virus Infection in the Department of Veterans Affairs (VA)
  68. Epidemiologic Review of Department of Veterans Affairs Patients With Isolation of Non-Tuberculous Mycobacteria After Cardiopulmonary Bypass Procedures
  69. Carbapenem-Resistant Enterobacteriaceae and Antimicrobial Usage Within the Veterans Affairs Healthcare System: 2010–2014
  70. Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010–2012
  71. Reuse of Insulin Pens Among Multiple Patients at 2 Veterans Affairs Medical Centers
  72. Incidence of Medically-Attended Norovirus-Associated Acute Gastroenteritis in Four Veteran’s Affairs Medical Center Populations in the United States, 2011-2012
  73. Challenges in Surveillance for Chikungunya Virus (CHIKV) Infection
  74. Evaluation of PraedicoTM, A Next Generation Big Data Biosurveillance Application
  75. Pertussis Surveillance in Veterans Affairs Medical Centers in Western United States – 2010-2014
  76. Influenza Infection in the Department of Veterans Affairs (VA), 2014–2015
  77. Epidemiologic Review of Carbapenem-Resistant Enterobacteriaceae and Duodenoscopes in the Department of Veterans Affairs
  78. Influenza Surveillance in the Department of Veterans Affairs (VA): 2012-2013 Influenza Season
  79. 1292Incidence of norovirus-associated acute gastroenteritis in four Veteran's Affairs Medical Center populations in the United States, 2011-2012
  80. 1064Influenza Infection in the Department of Veterans Affairs (VA): 2013-2014
  81. Combining Surveillance Systems: Effective Merging of U.S. Veteran and Military Health Data
  82. Does Antimicrobial Prescription Data Improve Influenza Surveillance in VA?
  83. Coverage and Timeliness of Combined Military and Veteran Surveillance Systems
  84. Enhanced Influenza Surveillance using Telephone Triage Data in the VA ESSENCE Biosurveillance System
  85. Characteristics of Veterans Accessing the Veterans Affairs Telephone Triage Who Have Depression or Suicidal Ideation: Opportunities for Intervention
  86. Dengue Surveillance in Veterans Affairs Healthcare Facilities, 2007–2010
  87. Concurrent outbreaks with co-infection of norovirus and Clostridium difficile in a long-term-care facility
  88. Vascular access hemorrhages contribute to deaths among hemodialysis patients
  89. Results from a Large-Scale Epidemiologic Look-Back Investigation of Improperly Reprocessed Endoscopy Equipment
  90. Comparative Assessment of Antimicrobial Usage Measures in the Department of Veterans Affairs
  91. Another type of cluster monitoring: detection of groups of anomalous patient residence locations
  92. Inpatient data: a new frontier in Veterans Affairs biosurveillance and public health monitoring from the electronic health record
  93. Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks
  94. Enhanced health event detection and influenza surveillance using a joint Veterans Affairs and Department of Defense biosurveillance application
  95. A Comparison of Manual and Electronic Dengue Surveillance in Puerto Rico Veterans Affairs Facilities, 2010
  96. Correlation of Annual Precipitation with Dengue Infections in Puerto Rico Veterans Affairs Facilities, 2007-2010
  97. Effective Detection of the 2009 H1N1 Influenza Pandemic in U.S. Veterans Affairs Medical Centers Using a National Electronic Biosurveillance System
  98. Cluster of necrotizing enterocolitis in a neonatal intensive care unit: New Mexico, 2007
  99. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States
  100. Enhanced Detection of Health Events through Biosurveillance in a Joint Veterans Affairs and Department of Defense Medical Center
  101. An Examination of Attitudes, Knowledge, and Clinical Practices Among Pennsylvania Pediatricians Regarding Breastfeeding and Smoking
  102. What Do Mothers Think About Concurrent Breast-Feeding and Smoking?
  103. CTNS Mutations in African American Patients with Cystinosis
  104. Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations
  105. Pulmonary Function and High-Resolution CT Findings in Patients With an Inherited Form of Pulmonary Fibrosis, Hermansky-Pudlak Syndrome, Due to Mutations in HPS-1
  106. Mutations of CTNS Causing Intermediate Cystinosis
  107. Breakpoint Identification, Detection and Frequency of the 65-kb Deletion in the Cystinosis Gene, CTNS
  108. Identification and Detection of the Common 65-kb Deletion Breakpoint in the Nephropathic Cystinosis Gene (CTNS)